Does genetic carrier screening treat BRCA gene mutation?

Genetic carrier screening does not treat a BRCA gene mutation; it provides information for planning. Screening examines genetic material to look for selected inherited changes. It cannot remove or repair a mutation, and it is not a treatment for cancer or for inherited cancer risk.

A BRCA1 or BRCA2 result may relate to inherited risk and can have implications for relatives. The meaning depends on the exact variant, the test used, personal health history, and family history. A result may be positive, negative, or uncertain, and an uncertain result does not establish a diagnosis or determine a treatment plan.

Discuss why testing is being offered before giving a sample, including whether the test is designed for carrier status or hereditary cancer risk. Review the result with a qualified genetics professional or clinician who can explain its limitations and possible next steps. Depending on the result and your history, care may involve tailored screening, risk-reduction discussions, or referral to an oncology team.

Contact your healthcare team promptly if you have a new breast, ovarian, prostate, or pancreatic symptom, receive a result that needs explanation, or learn that a close relative has a relevant genetic finding. Urgent help is appropriate for severe symptoms such as heavy bleeding, chest pain, breathing difficulty, or sudden neurological changes.

Ask which gene changes the test assesses, whether it is appropriate for your family history, what each possible result could mean, and who will explain it. Also ask what surveillance or risk-reduction options might be considered if a clinically meaningful BRCA finding is confirmed.